Biotricity, Inc. (BTCY)

Market Cap	10.46M
Revenue (ttm)	13.27M
Net Income (ttm)	-14.32M
Shares Out	24.91M
EPS (ttm)	-0.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,860
Average Volume	31,943
Open	0.5000
Previous Close	0.4697
Day's Range	0.4200 - 0.5000
52-Week Range	0.1860 - 1.6000
Beta	1.34
RSI	50.21
Earnings Date	Jun 27, 2025

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity, Inc. is based in Redwood City,...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Waqaas Al-Siddiq
• Employees: 55
• Stock Exchange: OTCMKTS
• Ticker Symbol: BTCY

Financial Performance

In 2023, Biotricity's revenue was $12.06 million, an increase of 25.15% compared to the previous year's $9.64 million. Losses were -$14.93 million, -23.57% less than in 2022.